Omeros Corporation ( OMER) - Key Metrics
OMER Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.40 | $0.18 | $0.06 | $0.06 |
| 2026Q1 | $0.14 | $0.78 | -$0.20 | -$0.20 |
| 2025Q4 | $0 | $1.36 | -$0.63 | -$0.63 |
| 2025Q3 | $0 | -$0.47 | -$0.28 | -$0.28 |
| 2025Q2 | $0 | -$0.43 | -$0.37 | -$0.37 |
OMER Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 13.21 |
| 2026Q1 | 0% | 3.38 |
| 2025Q4 | 0% | 3.02 |
| 2025Q3 | 0% | -2.18 |
| 2025Q2 | 0% | -1.74 |
OMER Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.60% | 0% |
| 2026Q1 | -1.91% | 0% |
| 2025Q4 | -3.65% | 0% |
| 2025Q3 | -6.80% | 0% |
| 2025Q2 | -12.49% | 0% |
OMER
Price: $18.79
52 week price:
Earnings Per Share: 1.65 USD
P/E Ratio: 10.42
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 328300
Ebitda: -4.6 millionMarket Capitalization: 1.3 billion